Medicine and Dentistry
Methotrexate
100%
Rituximab
73%
Patient
66%
Rheumatoid Arthritis
20%
Disability
20%
Short Form 36
20%
Health
20%
Pain
13%
Fatigue
13%
Minimal Clinically Important Difference
13%
Therapeutic Procedure
13%
Combination Therapy
6%
Chronic Disease
6%
Disease Activity
6%
Infusion
6%
Functional Assessment
6%
Drug
6%
Retreatment
6%
Chemotherapeutic Agent
6%
Erythrocyte Sedimentation Rate
6%
Assessment
6%
Joint
6%
Patient Characteristics
6%
Nursing and Health Professions
Methotrexate
100%
Rituximab
73%
Inpatient
26%
Quality of Life
20%
Disability
20%
Patient-Reported Outcome
20%
Short Form 36
20%
Rheumatoid Arthritis
20%
Dose
20%
Pain
13%
Minimal Clinically Important Difference
13%
Fatigue
13%
Chronic Disease
6%
Combination Therapy
6%
Infusion
6%
Disease Activity
6%
Functional Assessment
6%
Retreatment
6%
Drug
6%
Erythrocyte Sedimentation Rate
6%
Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
Rituximab
73%
Rheumatoid Arthritis
20%
Disability
20%
Pain
13%
Fatigue
13%
Chronic Disease
6%
Drug
6%
Disease Activity
6%